Viewing Study NCT06118151


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-21 @ 4:26 AM
Study NCT ID: NCT06118151
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2023-10-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module